BE901224A - Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation. - Google Patents

Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.

Info

Publication number
BE901224A
BE901224A BE0/214125A BE214125A BE901224A BE 901224 A BE901224 A BE 901224A BE 0/214125 A BE0/214125 A BE 0/214125A BE 214125 A BE214125 A BE 214125A BE 901224 A BE901224 A BE 901224A
Authority
BE
Belgium
Prior art keywords
intermediates
preparation
indole derivatives
medicaments
methods
Prior art date
Application number
BE0/214125A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BE901224A publication Critical patent/BE901224A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Nouveaux dérivés de l'indole de la formule générale (I), dans laquelle les substituants possèdent des significations définies, procédés pour leur préparation tels qu'une cyclisation d'un composé de la formule générale (II) et utilisation de ces composés de leurs sels physiologiquement acceptables et de produits de solvatation, qui possèdent une action vasoconstrictrice, pour le traitement de douleurs comme la migraine; composés intermédiaires et compositions pharmaceutique contenant ces substances.
BE0/214125A 1983-12-06 1984-12-06 Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation. BE901224A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838332435A GB8332435D0 (en) 1983-12-06 1983-12-06 Chemical compounds

Publications (1)

Publication Number Publication Date
BE901224A true BE901224A (fr) 1985-06-06

Family

ID=10552845

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214125A BE901224A (fr) 1983-12-06 1984-12-06 Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.

Country Status (27)

Country Link
US (1) US4994483A (fr)
JP (2) JPH062733B2 (fr)
KR (1) KR850004459A (fr)
CN (2) CN85104233A (fr)
AT (1) AT381934B (fr)
AU (1) AU575365B2 (fr)
BE (1) BE901224A (fr)
CA (1) CA1233183A (fr)
CH (1) CH663411A5 (fr)
CY (1) CY1562A (fr)
DE (1) DE3444572C2 (fr)
DK (2) DK583684A (fr)
ES (2) ES8607234A1 (fr)
FI (1) FI80260C (fr)
FR (1) FR2555987B1 (fr)
GB (2) GB8332435D0 (fr)
HK (1) HK85690A (fr)
HU (2) HU196752B (fr)
IL (1) IL73756A (fr)
IT (1) IT1178268B (fr)
NL (1) NL8403719A (fr)
NO (1) NO162764C (fr)
NZ (1) NZ210469A (fr)
PT (1) PT80572B (fr)
SE (1) SE458446B (fr)
SG (1) SG65790G (fr)
ZA (1) ZA849498B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
AU584142B2 (en) * 1984-12-04 1989-05-18 Glaxo Group Limited Indole derivatives
GB8430624D0 (en) * 1984-12-04 1985-01-09 Glaxo Group Ltd Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
JPH01312506A (ja) * 1988-06-13 1989-12-18 Mitsui Petrochem Ind Ltd カラーフィルター
HU219974B (hu) * 1990-06-07 2001-10-28 Astrazeneca Ab, Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
ES2055651B1 (es) * 1992-07-20 1995-03-01 Vita Invest Sa Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
IT1264813B1 (it) * 1993-07-28 1996-10-10 Oxon Italia Spa Procedimento per la preparazione di alcansolfonammidi
EP0875513A1 (fr) * 1997-04-14 1998-11-04 Eli Lilly And Company Composés hétéroaromatiques substitués agonistes du récepteur 5-HT1F
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9926250D0 (en) * 1999-11-06 2000-01-12 Knoll Ag Chemical process
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
CN1729174B (zh) * 2002-12-20 2015-10-21 西巴特殊化学品控股有限公司 胺的合成以及用于合成胺的中间体
WO2004099141A1 (fr) * 2003-05-12 2004-11-18 Ramesh Babu Potluri Nouveau procede pour la preparation de derives d'indole
EP1765300A2 (fr) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulations de sumatriptan absorbables au travers des membranes biologiques, et methodes de production et d'utilisation desdites formulations
ZA200709038B (en) 2005-04-13 2009-01-28 Neuraxon Inc Substituted indole compounds having nos inhibitory activity
CA2643822A1 (fr) * 2006-04-13 2007-10-25 Neuraxon, Inc Indoles 1,5- et 3,6-substitues a activite inhibitrice vis-a-vis de nos
WO2008056378A2 (fr) * 2006-11-09 2008-05-15 Natco Pharma Limited Nouveau procédé destiné à la préparation de naratriptan
CA2677838C (fr) * 2007-02-11 2017-08-01 Map Pharmaceuticals, Inc. Procede d'administration therapeutique de dhe pour procurer un soulagement rapide de la migraine tout en minimisant le profil des effets secondaires
CA2705422A1 (fr) * 2007-11-16 2009-05-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Procedes de traitement de la douleur viscerale
US20090131503A1 (en) * 2007-11-16 2009-05-21 Annedi Subhash C 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
NZ586082A (en) 2007-11-16 2013-03-28 Neuraxon Inc Indole compounds and methods for treating visceral pain
US20110171141A1 (en) * 2009-06-26 2011-07-14 Kellerman Donald J Administration of dihydroergotamine mesylate particles using a metered dose inhaler
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
EP2480197B1 (fr) 2009-09-25 2015-11-11 Dr. Reddy's Laboratories Ltd. Formulations comprenant des composés triptan
JPWO2012165262A1 (ja) * 2011-05-27 2015-02-23 国立大学法人徳島大学 ベンジルアミン誘導体
EP2734634B1 (fr) 2011-07-22 2019-08-21 The University of Chicago Igf-1 pour le traitement de la migraine
CN102827062A (zh) * 2012-09-17 2012-12-19 扬子江药业集团四川海蓉药业有限公司 苹果酸阿莫曲坦的制备方法
US9394314B2 (en) 2012-12-21 2016-07-19 Map Pharmaceuticals, Inc. 8′-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322787A (en) * 1964-09-25 1967-05-30 Merck & Co Inc Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
IT1036004B (it) * 1968-05-21 1979-10-30 Abc Ist Biolog Chem Spa Acidt 3 indolil adetoidrossamici
US3730723A (en) * 1971-06-17 1973-05-01 Eastman Kodak Co Direct positive processes utilizing silver halide surface image emulsions containing desensitizers
US4283410A (en) * 1978-06-15 1981-08-11 Miles Laboratories, Inc. 3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
BE889929A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives de l'indole, leur preparation et leurs utilisations therapeutiques
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
AU584142B2 (en) * 1984-12-04 1989-05-18 Glaxo Group Limited Indole derivatives

Also Published As

Publication number Publication date
FR2555987B1 (fr) 1987-07-17
GB8430810D0 (en) 1985-01-16
AT381934B (de) 1986-12-10
FI80260B (fi) 1990-01-31
IT8449265A0 (it) 1984-12-06
FR2555987A1 (fr) 1985-06-07
FI844789L (fi) 1985-06-07
FI80260C (fi) 1990-05-10
PT80572A (en) 1985-06-01
NZ210469A (en) 1989-01-27
DK583684A (da) 1985-06-07
GB2150932B (en) 1987-10-28
US4994483A (en) 1991-02-19
IL73756A0 (en) 1985-03-31
SE458446B (sv) 1989-04-03
FI844789A0 (fi) 1984-12-05
GB2150932A (en) 1985-07-10
CA1233183A (fr) 1988-02-23
AU3636784A (en) 1985-06-13
GB8332435D0 (en) 1984-01-11
KR850004459A (ko) 1985-07-15
JPS60155156A (ja) 1985-08-15
AU575365B2 (en) 1988-07-28
SE8406200L (sv) 1985-06-07
SG65790G (en) 1990-10-26
DE3444572A1 (de) 1985-06-20
CY1562A (en) 1991-05-17
NO162764B (no) 1989-11-06
ES546631A0 (es) 1987-10-16
HU196752B (en) 1989-01-30
JPH03184958A (ja) 1991-08-12
ZA849498B (en) 1986-09-24
CN1015055B (zh) 1991-12-11
IL73756A (en) 1988-02-29
CN85106225A (zh) 1987-02-18
PT80572B (en) 1986-12-22
HUT40624A (en) 1987-01-28
ES538336A0 (es) 1986-06-01
JPH062733B2 (ja) 1994-01-12
NL8403719A (nl) 1985-07-01
DK214090D0 (da) 1990-09-06
DK214090A (da) 1990-09-06
CN85104233A (zh) 1987-01-07
HUT36455A (en) 1985-09-30
ES8607234A1 (es) 1986-06-01
DE3444572C2 (de) 1993-10-14
ATA387384A (de) 1986-05-15
CH663411A5 (fr) 1987-12-15
DK583684D0 (da) 1984-12-06
ES8800150A1 (es) 1987-10-16
NO162764C (no) 1990-02-14
IT1178268B (it) 1987-09-09
HK85690A (en) 1990-10-25
SE8406200D0 (sv) 1984-12-06
NO844879L (no) 1985-06-07

Similar Documents

Publication Publication Date Title
BE901224A (fr) Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation.
FR2430412A1 (fr) Derives substitues de propanolamine utiles comme medicaments et procede de leur preparation
FR2416234A1 (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
MA26733A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA28747B1 (fr) Dérivés de pyridine
MA25035A1 (fr) Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant
BE903334A (fr) Nouveaux derives naphtaleniques a action retinoique, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
BE902953A (fr) Derives de 5h-2,3-benzodiazepine procede pour les preparer et compositions pharmaceutiques les contenant
FR2444031A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
BE899132A (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2375187A1 (fr) Cyclopentane-1-amines, procede pour leur preparation et produits contenant ces composes
FR2403989A1 (fr) Nouveaux derives a-halogenomethyles d'amines utiles comme medicaments et procedes de leur preparation
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2433527A1 (fr) Nouveaux derives de type pyrimidinone, procede pour leur preparation et composition pharmaceutique les contenant
FR2394542A1 (fr) Derives de 3-(1-pyrazolyl)-pyridazine et leur procede de preparation et nouveaux medicaments les contenant
FR2370744A1 (fr) Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
FR2358382A1 (fr) Nouveaux nonapeptides, leurs procedes de preparation et compositions pharmaceutiques les contenant
FR2354766A1 (fr) Derives n-aminoalkyles d'indole et procedes pour les preparer
FR2362845A1 (fr) Nouveaux derives de o-(3-amino-2-hydroxy-propyl)-amidoxime, procede pour leur preparation et compositions pharmaceutiques les contenant
BE900178A (fr) Urees et thio-urees anti-atherosclerotiques.
BE903376A (fr) Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant
MA19952A1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et les compositions pharmaceutiques les renfermant
BE902249A (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD

Effective date: 19911231